Evaluation of Exenatide in Patients With Diabetic Neuropathy

NCT00855439 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Diabetic Peripheral Neuropathy

Interventions

DRUG: Exenatide
DRUG: Glargine

Sponsor

University of Michigan

Collaborators

[object Object]
[object Object]